Anzeige
Mehr »
Login
Freitag, 21.03.2025 Börsentäglich über 12.000 News von 692 internationalen Medien
Jetzt einsteigen, bevor der Boom beginnt: Diese bahnbrechende Technologie erobert den Markt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3E2F3 | ISIN: US23254L8019 | Ticker-Symbol: UXI
Lang & Schwarz
20.03.25
22:59 Uhr
0,296 Euro
-0,296
-100,00 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
CYCLACEL PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
CYCLACEL PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,2940,29820.03.

Aktuelle News zur CYCLACEL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
27.02.Cyclacel Pharmaceuticals Announces Closing of a Change of Control Transaction and Appointment of New Executive Leadership2
24.02.Cyclacel Pharmaceuticals, Inc. - 8-K, Current Report-
12.02.Cyclacel Pharmaceuticals, Inc. - 8-K, Current Report-
05.02.Cyclacel Pharmaceuticals, Inc. - 8-K, Current Report-
06.01.Cyclacel Pharmaceuticals, Inc. - 8-K, Current Report9
03.01.Why Cyclacel Pharmaceuticals (CYCC) Stock Is Skyrocketing6
03.01.David Lazar acquires Cyclacel Pharmaceuticals preferred stock, becomes interim CEO; stock jumps3
CYCLACEL Aktie jetzt für 0€ handeln
03.01.Cyclacel Pharmaceuticals Announces Agreement for the Acquisition of Preferred Stock by David Lazar9
03.01.Investor pumps $3M into cash-strapped Cyclacel in return for CEO role-
12.12.24Cyclacel Pharmaceuticals, Inc. - 8-K, Current Report2
06.12.24Cash-strapped Cyclacel cuts costs as it searches for financial lifeline2
05.12.24Cyclacel Pharmaceuticals Announces Its Exploration of Potential Strategic Alternatives and Reduction of Operating Costs135BERKELEY HEIGHTS, N.J., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...
► Artikel lesen
14.11.24Cyclacel Pharmaceuticals Announces Closing of Exercise of Warrants for $2.1 Million Gross Proceeds1
13.11.24Cyclacel Pharmaceuticals Announces Exercise of Warrants for $2.1 Million Gross Proceeds3
13.11.24Cyclacel Pharmaceuticals GAAP EPS of -$0.18 beats by $0.36, revenue of $0.01M in-line1
12.11.24Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update176BERKELEY HEIGHTS, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...
► Artikel lesen
12.11.24Cyclacel Pharmaceuticals, Inc. - 10-Q, Quarterly Report-
12.11.24Cyclacel Pharmaceuticals, Inc. - 8-K, Current Report-
24.10.24Cyclacel Pharmaceuticals, Inc. - 8-K, Current Report5
24.10.24Cyclacel Pharmaceuticals Announces That Nasdaq Granted an Extension to Regain Compliance With the Equity Standard Rule208BERKELEY HEIGHTS, N.J., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...
► Artikel lesen
Seite:  Weiter >>
29 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1